These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20040247)

  • 41. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome.
    Schmidauer C; Sojer M; Seppi K; Stockner H; Högl B; Biedermann B; Brandauer E; Peralta CM; Wenning GK; Poewe W
    Ann Neurol; 2005 Oct; 58(4):630-4. PubMed ID: 16037973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism.
    Todd G; Pearson-Dennett V; Wilcox RA; Chau MT; Thoirs K; Thewlis D; Vogel AP; White JM
    Parkinsonism Relat Disord; 2016 Apr; 25():27-32. PubMed ID: 26923520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression.
    Vilas D; Iranzo A; Pont-Sunyer C; Serradell M; Gaig C; Santamaria J; Tolosa E
    J Neurol; 2015 Jul; 262(7):1665-72. PubMed ID: 25929659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between systemic iron parameters and substantia nigra iron stores in restless legs syndrome.
    Garcia-Malo C; Novo-Ponte S; Castro-Villacañas Farzamnia A; Boi S; Miranda Castillo C; Romero Peralta S; Martínez Vidal V; Botta L; Anguizola S; Cano-Pumarega I; Garcia-Borreguero D
    Sleep Med; 2021 Sep; 85():191-195. PubMed ID: 34343769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology of transcranial sonography signal changes in the human substantia nigra.
    Double KL; Todd G; Duma SR
    Int Rev Neurobiol; 2010; 90():107-20. PubMed ID: 20692497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Usefulness of transcranial sonography in Parkinson's disease. A comparative study using 123I-FP-CIT SPECT].
    Hernández Vara J; Rubiera del Fueyo M; Lorenzo Bosquet C; Castell Conesa J; Molina Cateriano CA; Rodríguez FM
    Med Clin (Barc); 2008 Sep; 131(8):285-9. PubMed ID: 18803921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
    Warton FL; Howells FM; Russell VA
    Metab Brain Dis; 2009 Dec; 24(4):599-613. PubMed ID: 19821016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder.
    Picchietti DL; England SJ; Walters AS; Willis K; Verrico T
    J Child Neurol; 1998 Dec; 13(12):588-94. PubMed ID: 9881529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of substantia nigra echogenicity and motor function in elderly subjects.
    Berg D; Siefker C; Ruprecht-Dörfler P; Becker G
    Neurology; 2001 Jan; 56(1):13-7. PubMed ID: 11148229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography.
    Hagenah J; König IR; Sperner J; Wessel L; Seidel G; Condefer K; Saunders-Pullman R; Klein C; Brüggemann N
    Neuroimage; 2010 May; 51(1):28-32. PubMed ID: 20152909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ultra early diagnosis of Parkinson's disease by the enhanced substantia nigra echo.
    Zhuang JJ; Zheng YH; Xu XW; Zhou L
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4621-6. PubMed ID: 26698260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain tissue echogenicity--implications for substantia nigra studies in parkinsonian patients.
    Sadowski K; Szlachta K; Serafin-Król M; Gałązka-Friedman J; Friedman A
    J Neural Transm (Vienna); 2012 Mar; 119(3):363-7. PubMed ID: 21881837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder.
    Kim JI; Kim JW; Lee JM; Yun HJ; Sohn CH; Shin MS; Kim B; Chae J; Roh J; Kim BN
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():169-176. PubMed ID: 29169998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.
    Iova A; Garmashov A; Androuchtchenko N; Kehrer M; Berg D; Becker G; Garmashov Y
    J Neurol; 2004 Dec; 251(12):1451-4. PubMed ID: 15645343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcranial sonography imaging of brainstem raphe, substantia nigra and cerebral ventricles in patients with geriatric depression.
    Şenel B; Özel-Kızıl ET; Sorgun MH; Tezcan-Aydemir S; Kırıcı S
    Int J Geriatr Psychiatry; 2020 Jul; 35(7):702-711. PubMed ID: 32100326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
    Ernst M; Zametkin AJ; Matochik JA; Pascualvaca D; Jons PH; Cohen RM
    Am J Psychiatry; 1999 Aug; 156(8):1209-15. PubMed ID: 10450262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.